Riskpilot← Back to searchSign inGet full accessSandwallskliniken Wallander AB
ABActiveOrg 5569716946Lilla Kyrkogatan 27Dental practice care activities · NACE 8623Est. 20141 employees
Revenue 2025
SEK 0
EBITDA margin
—
-6039% vs 2024
Equity ratio
58.3%
Financial strength
Net profit 2025
SEK -57K
-110% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,8M | -6039% |
| Net profit | SEK -57K | -110% |
| Total assets | SEK 2,7M | -14% |
| Equity | SEK 1,6M | -3% |
| Employees | 1 | — |
Legal name
Sandwallskliniken Wallander AB
Org number
5569716946
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
15 maj 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva tandvård, försäljning av dentalmaterial och kursverksamhet inom tandvård samt därmed idka förenlig verksamhet.
Address
Lilla Kyrkogatan 27
Email
erik.wallander@me.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 732 | 7 773 | 7 120 | 61 | 0 |
| Staff expenses | — | — | — | −1 814 | — |
| EBITDA | 844 | 798 | 181 | 30 | −1 772 |
| Depreciation & amort. | −2 | −0 | −34 | — | −0 |
| EBIT | 842 | 798 | 147 | 30 | −1 772 |
| Net financials | −130 | −318 | −314 | 690 | 1 715 |
| Profit before tax | 720 | 607 | −24 | 720 | −57 |
| Tax | −162 | −162 | −28 | −132 | −0 |
| Net profit | 558 | 445 | −52 | 588 | −57 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 126 | 2 100 | 1 525 | 3 181 | 2 727 |
| Equity | 1 365 | 1 410 | 1 109 | 1 647 | 1 590 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 760 | 690 | 416 | 1 534 | 1 136 |
| Total debt | 760 | 690 | 416 | 1 534 | 1 136 |
EBITDA margin
-177200000.0%
This company
15.8%
Market median
-1121519087% vs market
20212025
Equity ratio
58.3%
This company
38.2%
Market median
+53% vs market
20212025
Return on equity
-3.6%
This company
18.4%
Market median
-120% vs market
20212025
Net profit margin
-5700000.0%
This company
8.1%
Market median
-70370470% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PB Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
GL | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sandwallskliniken Wallander AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Bo Weine Karlsson | Chief Auditor | 0 companies |
| Gun-Lis Linnea Bellhem | Audit | 0 companies |
| Bengt Erik Oskar Wilhelm Wallander | Board of Directors | 0 companies |
| Hanna Terese Roos Wallander | Deputy Board Member | 0 companies |